Abstract
Arrhythmias and sudden cardiac death resulting from ventricular tachycardia/fibrillation are important public health issues of this decade. Complexities surrounding the subject, plus a relatively experimental and toxic therapeutic armamentarium with poorly defined end points, have largely limited the field to the specialized cardiologist. Recent studies, however, have served to identify those at risk as a result of their dysrhythmia,, and given the improved methods for detection and monitoring and a host of potent new antiarrhythmic drugs, interest in the area is certain to broaden. Inasmuch as initial presentation and follow-up often lie within the realm of the family physician or generalist, an understanding and update of this important subject is in order.
Keywords: electrophysiology, classification, indications to treat
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Campbell R. W. Mexiletine. N Engl J Med. 1987 Jan 1;316(1):29–34. doi: 10.1056/NEJM198701013160106. [DOI] [PubMed] [Google Scholar]
- Huang S. K., Marcus F. I. Antiarrhythmic drug therapy of ventricular arrhythmias. Curr Probl Cardiol. 1986 Apr;11(4):177–240. doi: 10.1016/0146-2806(86)90016-2. [DOI] [PubMed] [Google Scholar]
- Kennedy H. L., Whitlock J. A., Sprague M. K., Kennedy L. J., Buckingham T. A., Goldberg R. J. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med. 1985 Jan 24;312(4):193–197. doi: 10.1056/NEJM198501243120401. [DOI] [PubMed] [Google Scholar]
- Podrid P. J. Antiarrhythmic drug therapy (Part 2). Benefits and hazards. Chest. 1985 Oct;88(4):618–624. doi: 10.1378/chest.88.4.618. [DOI] [PubMed] [Google Scholar]
- Pratt C. M., Luck J. C., Mann D. E., Wyndham C. R. Investigational antiarrhythmic drugs for the treatment of ventricular rhythm disturbances. Cardiol Clin. 1984 Feb;2(1):35–46. [PubMed] [Google Scholar]
- Roden D. M. Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents. Postgrad Med. 1985 Sep 15;78(4):28–37. doi: 10.1080/00325481.1985.11699135. [DOI] [PubMed] [Google Scholar]
- Roden D. M., Woosley R. L. Drug therapy. Flecainide. N Engl J Med. 1986 Jul 3;315(1):36–41. doi: 10.1056/NEJM198607033150106. [DOI] [PubMed] [Google Scholar]
- Roden D. M., Woosley R. L. Drug therapy. Tocainide. N Engl J Med. 1986 Jul 3;315(1):41–45. doi: 10.1056/NEJM198607033150107. [DOI] [PubMed] [Google Scholar]
- Somberg J. C., Miura D., Keefe D. L. The treatment of ventricular rhythm disturbances. Am Heart J. 1986 Jun;111(6):1162–1176. doi: 10.1016/0002-8703(86)90021-9. [DOI] [PubMed] [Google Scholar]